Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 5/20 | 0.71 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.71 |
| ▸ | PDE4B | Q07343 | 5/20 | 0.71 |
| ▸ | PDE4C | Q08493 | 5/20 | 0.71 |
| ▸ | PDE4D | Q08499 | 5/20 | 0.71 |
| ▸ | BRD4 | O60885 | 5/20 | 0.68 |
| ▸ | BRD2 | P25440 | 2/20 | 0.68 |
| ▸ | BRD3 | Q15059 | 2/20 | 0.68 |
| ▸ | BRDT | Q58F21 | 2/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1495090 | 0.89 | PDE4A (0.76) | PDE4AADORA2APDE4BPDE4CPDE4D | |
| SCHEMBL4566277 | 0.86 | MEN1 (0.77) | PDE4AADORA2APDE4BPDE4CPDE4D | |
| SCHEMBL16675435 | 0.86 | MAPK1 (0.64) | PDE4AADORA2APDE4BPDE4CPDE4D | |
| SCHEMBL10955005 | 0.86 | MAPK1 (0.64) | PDE4AADORA2APDE4BPDE4CPDE4D | |
| SCHEMBL25286006 | 0.85 | ALDH1A1 (0.71) | PDE4AADORA2APDE4BPDE4CPDE4D | |
| SCHEMBL17682204 | 0.85 | MAPK1 (0.59) | PDE4AADORA2APDE4BPDE4CPDE4D | |
| SCHEMBL17682216 | 0.84 | SMN1; SMN2 (0.64) | PDE4AADORA2APDE4BPDE4CPDE4D | |
| SCHEMBL516463 | 0.84 | PDE4A (0.81) | PDE4AADORA2APDE4BPDE4CPDE4D | |
| SCHEMBL7464093 | 0.84 | MAPK1 (0.57) | PDE4AADORA2APDE4BPDE4CPDE4D | |
| SCHEMBL11400162 | 0.84 | MEN1 (0.69) | PDE4AADORA2APDE4BPDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748455-A1 | ANTI-GREY-HAIR COMPOSITION COMPRISING PLANT EXTRACTS | Wella Germany GmbH (DE) | 2026-05-27 | — | — | EP | disclosed |
| EP-4748454-A1 | ANTI-GREY-HAIR COMPOSITION | Wella Germany GmbH (DE) | 2026-05-27 | — | — | EP | disclosed |
| US-20260137750-A1 | ANTI-GREY-HAIR COMPOSITION | WELLA GERMANY GMBH (DE) | 2026-05-21 | — | — | US | disclosed |
| US-20250179130-A1 | METHODS AND SYSTEMS FOR DESIGNING AND/OR CHARACTERIZING SOLUBLE LIPIDATED LIGAND AGENTS | ON TARGET THERAPEUTICS LLC | 2025-06-05 | — | — | US | disclosed |
| EP-4545063-A1 | COSMETICAL USE OF A TOPICALLY APPLICABLE RINSE-OF COMPOSITION (RC) | Wella Germany GmbH (DE) | 2025-04-30 | — | — | EP | disclosed |
| CN-119868176-A | Cosmetic use of a topically applicable rinse-off composition (RC) | 威娜德国有限责任公司 | 2025-04-25 | — | — | CN | disclosed |
| US-20250127701-A1 | Cosmetical use of a topically applicable rinse-of composition (RC) | WELLA GERMANY GMBH (DE) | 2025-04-24 | — | — | US | disclosed |
| EP-4531801-A1 | IMPROVING HAIR STRUCTURE | Wella Germany GmbH (DE) | 2025-04-09 | — | — | EP | disclosed |
| EP-4262738-B1 | METHOD FOR OBTAINING AQUEOUS EXTRACTS OF TEA LEAVES, COMPOSITIONS COMPRISING SUCH EXTRACTS AND COSMETIC USES THEREOF | ISP INVESTMENTS LLC (US) | 2025-02-19 | — | — | EP | disclosed |
| US-20240374503-A1 | BLACK TEA LEAF EXTRACT, COMPOSITIONS CONTAINING SAME, AND COSMETIC USES THEREOF | ISP INVESTMENTS LLC | 2024-11-14 | — | — | US | disclosed |
| US-20020034485-A1 | Hair tonic for prevention or treatment of hair loss | WELLA AKTIENGESELLSCHAFT (DE) | 2002-03-21 | — | — | US | disclosed |
| EP-1179334-A2 | Hair tonic for preventing or treating hair loss | Wella Aktiengesellschaft (DE) | 2002-02-13 | — | — | EP | disclosed |
| EP-0771813-B1 | Alkylxanthine phosphonates and alkylxanthine phosphine oxydes and their use as medicines | HOECHST AG (DE) | 2002-01-16 | — | — | EP | disclosed |
| CN-1058855-C | Sweet tea and its prepn | SHI YULIN (CN) | 2000-11-29 | — | — | CN | disclosed |
| US-5728686-A | TREATMENT OF MUSCULAR DYSTROPHY | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-03-17 | — | — | US | disclosed |
| CN-1158855-A | Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmacueticals | HOECHST AG (DE) | 1997-09-10 | — | — | CN | disclosed |
| EP-0771813-A1 | Alkylxanthine phosphonates and alkylxanthine phosphine oxydes and their use as medicines | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-05-07 | — | — | EP | disclosed |
| US-4904773-A | FORMING COMPLEXES WITH CYCLODEXTRIN | ALLELIX INC. (CA) | 1990-02-27 | — | — | US | disclosed |
| US-4289776-A | VASODILATORS, FIBRINOLYTIC | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-09-15 | — | — | US | disclosed |
| US-4108995-A | CEREBRAL BLOOD FLOW | HOECHST AKTIENGESELLSCHAFT (DE) | 1978-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137750-A1 | ANTI-GREY-HAIR COMPOSITION | OAT, CUTA, NASP | PDE4A 4009/4885ADORA2A 1900/4885PDE4B 3965/4885 |
| US-20250179130-A1 | METHODS AND SYSTEMS FOR DESIGNING AND/OR CHARACTERIZING SOLUBLE LIPIDATED LIGAND AGENTS | LDLR, HDLBP, LIPG | PDE4A 3357/4885ADORA2A 1114/4885PDE4B 3408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.